GLP-1 secretion by microglial cells and decreased CNS expression in obesityReport as inadecuate




GLP-1 secretion by microglial cells and decreased CNS expression in obesity - Download this document for free, or read online. Document in PDF available to download.

Journal of Neuroinflammation

, 9:276

First Online: 23 December 2012Received: 24 October 2012Accepted: 29 November 2012

Abstract

BackgroundType 2 diabetes T2D is a strong risk factor for developing neurodegenerative pathologies. T2D patients have a deficiency in the intestinal incretin hormone GLP-1, which has been shown to exert neuroprotective and anti-inflammatory properties in the brain.

MethodsHere we investigate potential sources of GLP-1 in the CNS and the effect of diabetic conditions on the proglucagon mRNA expression in the CNS. The obese mouse model ob-ob, characterized by its high levels of free fatty acids, and the microglia cell line BV-2 were used as models. mRNA expression and protein secretion were analyzed by qPCR, immunofluorescence and ELISA.

ResultsWe show evidence for microglia as a central source of GLP-1 secretion. Furthermore, we observed that expression and secretion are stimulated by cAMP and dependent on microglial activation state. We also show that insulin-resistant conditions reduce the central mRNA expression of proglucagon.

ConclusionThe findings that microglial mRNA expression of proglucagon and GLP-1 protein expression are affected by high levels of free fatty acids and that both mRNA expression levels of proglucagon and secretion levels of GLP-1 are affected by inflammatory stimuli could be of pathogenic importance for the premature neurodegeneration and cognitive decline commonly seen in T2D patients, and they may also be harnessed to advantage in therapeutic efforts to prevent or treat such disorders.

KeywordsGlucagon-like peptide-1 Microglia Neuroinflammation Neuroprotection Proglucagon AbbreviationsTNFαTumor necrosis factor α

GLP-1Glucagon-like peptide-1

PKAProtein kinase A

LPSLipopolysaccharide

T2DType 2 diabetes

Ym1chitinase 3-like 3.

Download fulltext PDF



Author: Camilla Kappe - Linda M Tracy - Cesare Patrone - Kerstin Iverfeldt - Åke Sjöholm

Source: https://link.springer.com/







Related documents